These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3444198)

  • 1. [Treatment and prognosis in cases of M. avium-intracellulare infection].
    Kekkaku; 1987 Nov; 62(11):575-601. PubMed ID: 3444198
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study on drug regimens against Mycobacterium avium-intracellulare infection (3). The therapeutic effect of some antimicrobial agents to murine infection model].
    Sakurai N
    Kekkaku; 1988 Jun; 63(6):447-60. PubMed ID: 3172623
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial intensive chemotherapy in tuberculosis.
    Prijyanonda B; Subcharoen S; Korkiat K; Chatrapolraks T; Dhumvipat P
    J Med Assoc Thai; 1973 Jul; 56(7):420-5. PubMed ID: 4805906
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection].
    Tsukamura M; Ichiyama S; Miyachi T
    Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
    Mineshita M; Miyazawa T; Doi M; Suei S; Matsuura M; Senoo T; Yamakido M
    Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
    Tsukamura M
    Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
    [No Abstract]   [Full Text] [Related]  

  • 10. [The present status of treatment of Mycobacterium avium complex infection].
    Harada S
    Kekkaku; 1996 Sep; 71(9):540-4. PubMed ID: 8999138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical features of the lung diseases due to Mycobacterium avium and M. intracellulare].
    Toyoda T; Aoyagi T; Saito H
    Kekkaku; 1993 Jan; 68(1):63-9. PubMed ID: 8437427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo chemotherapeutic activity of rifabutin (LM 427) on Mycobacterium avium-intracellulare complex.
    Sakurai N; Kuze F
    Bull Chest Dis Res Inst Kyoto Univ; 1987 Mar; 20(1-2):50-60. PubMed ID: 2836007
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. An analysis of Danish patients during the period 1962-1976.
    Engbaek HC; Vergmann B; Bentzon MW
    Eur J Respir Dis; 1981; 62(2):72-83. PubMed ID: 7238667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
    Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative drug susceptibility of opaque colonial forms of Mycobacterium intracellulare-avium: does it affect therapeutic results?
    Moulding T
    Am Rev Respir Dis; 1978 Jun; 117(6):1142-3. PubMed ID: 666109
    [No Abstract]   [Full Text] [Related]  

  • 16. [A clinical experience of DNA probe method for identifying Mycobacterium avium and Mycobacterium intracellulare].
    Tsuda M; Oishi N; Saeki A; Ogawa K; Honda K; Sasamoto M; Michihiro H; Miwa T
    Kekkaku; 1995 Jun; 70(6):369-76. PubMed ID: 7630072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
    Zhao T; Yang SR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
    Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M
    Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterial infections.
    Peloquin CA
    Pharmacotherapy; 1993; 13(6):634-9. PubMed ID: 8302690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.